āĻšā§āĻŽG1LP34 âĸ BVMF
add
Galapagos Nv Bdr
ā§Ŧ.ā§ā§ŽÂ R$
ā§Šā§Ļ āĻāĻžāĻ¨ā§, ā§¯:ā§Ēā§Š:ā§Ēā§ PM GMT -ā§Š · BRL · BVMF · āĻĄāĻŋāĻ¸āĻā§āĻ˛ā§āĻŽāĻžāĻ°
āĻāĻžāĻ˛ āĻļā§āĻˇ āĻ¯ā§ āĻĻāĻžāĻŽā§ āĻāĻŋāĻ˛
ā§Ŧ.ā§¯ā§Ļ R$
āĻ¸āĻžāĻ°āĻž āĻĻāĻŋāĻ¨ā§āĻ° āĻā§āĻ°ā§āĻĄāĻŋāĻā§ā§ āĻ¸ā§āĻāĻā§āĻ° āĻĻāĻžāĻŽā§āĻ° āĻāĻ āĻž āĻ¨āĻžāĻŽāĻžāĻ° āĻ°ā§āĻā§āĻ
ā§Ŧ.ā§ā§ŽÂ R$ - ā§Ŧ.ā§¯ā§¨Â R$
āĻ¸āĻžāĻ°āĻž āĻŦāĻāĻ°ā§āĻ° āĻ°ā§āĻā§āĻ
ā§Ŧ.ā§Ēā§Ŧ R$ - ā§§ā§Ļ.ā§Ļā§¨Â R$
āĻŽāĻžāĻ°ā§āĻā§āĻ āĻā§āĻ¯āĻžāĻĒ
ā§§ā§Ēā§.ā§Ļā§ŽÂ āĻā§ EUR
āĻāĻĄāĻŧ āĻāĻ˛āĻŋāĻāĻŽ
ā§Ŧā§Ŧ.ā§Ļā§Ļ
āĻŦāĻžāĻāĻžāĻ° āĻ¸āĻāĻŦāĻžāĻĻ
āĻĢāĻžāĻāĻ¨āĻžāĻ¨ā§āĻ¸āĻŋā§āĻžāĻ˛ āĻĒāĻžāĻ°āĻĢāĻ°ā§āĻŽā§āĻ¯āĻžāĻ¨ā§āĻ¸
āĻā§ā§āĻ° āĻ¸ā§āĻā§āĻāĻŽā§āĻ¨ā§āĻ
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ
(EUR) | āĻ¸ā§āĻĒ ā§¨ā§Ļā§¨ā§Ēinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
---|---|---|
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | ā§Ģ.ā§¯ā§ŽÂ āĻā§ | -ā§Ģā§Ļ.ā§§ā§Ē% |
āĻŦā§āĻ¯āĻŦāĻ¸āĻž āĻāĻžāĻ˛āĻžāĻ¨ā§āĻ° āĻāĻ°āĻ | ā§¨.ā§§ā§§Â āĻā§ | ā§§ā§§ā§¨.ā§Ģā§Ž% |
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | -ā§Ģ.ā§Ļā§Ē āĻā§ | -ā§¨ā§¯ā§Ģ.ā§¨ā§Ē% |
āĻ¨ā§āĻ āĻĒā§āĻ°āĻĢāĻŋāĻ āĻŽāĻžāĻ°ā§āĻāĻŋāĻ¨ | -ā§Žā§Ē.ā§¨ā§Ŧ | -ā§Ēā§¯ā§§.ā§Ģā§Ē% |
āĻļā§ā§āĻžāĻ° āĻĒā§āĻ°āĻ¤āĻŋ āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | -ā§Ļ.ā§ā§Ē | -ā§¨ā§Žā§¯.ā§ā§Ē% |
EBITDA | -ā§Ē.ā§Žā§Ģ āĻā§ | -ā§Žā§Ŧ.ā§Ļā§¨% |
āĻĒā§āĻ°āĻ¯ā§āĻā§āĻ¯ āĻā§āĻ¯āĻžāĻā§āĻ¸ā§āĻ° āĻšāĻžāĻ° | ā§§.ā§§ā§Ŧ% | â |
āĻŦā§āĻ¯āĻžāĻ˛ā§āĻ¨ā§āĻ¸ āĻļāĻŋāĻ
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
(EUR) | āĻ¸ā§āĻĒ ā§¨ā§Ļā§¨ā§Ēinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
---|---|---|
āĻā§āĻ¯āĻžāĻļ āĻ āĻāĻŽ āĻ¸āĻŽā§ā§āĻ° āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ | ā§Šā§Šā§Š.ā§Žā§ŽÂ āĻā§ | -ā§§ā§¨.ā§Ēā§§% |
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ | ā§Ēā§§ā§.ā§¨ā§¨Â āĻā§ | -ā§Ŧ.ā§¨ā§% |
āĻŽā§āĻ āĻĻāĻžā§ | ā§§ā§Šā§Ļ.ā§¯ā§Ŧ āĻā§ | -ā§¨ā§Ž.ā§Ēā§Š% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§¨ā§Žā§Ŧ.ā§¨ā§Ŧ āĻā§ | â |
āĻāĻāĻāĻ¸ā§āĻā§āĻ¯āĻžāĻ¨ā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāĻ° | ā§Ŧ.ā§Ģā§¯Â āĻā§ | â |
āĻĒā§āĻ°āĻžāĻāĻ¸ āĻā§ āĻŦā§āĻ āĻ°ā§āĻļāĻŋāĻ | ā§Ļ.ā§§ā§Ŧ | â |
āĻ¸āĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | -ā§Š.ā§¨ā§§% | â |
āĻŽā§āĻ˛āĻ§āĻ¨ āĻĨā§āĻā§ āĻā§ | -ā§Ē.ā§Ŧā§¯% | â |
āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨
(EUR) | āĻ¸ā§āĻĒ ā§¨ā§Ļā§¨ā§Ēinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
---|---|---|
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | -ā§Ģ.ā§Ļā§Ē āĻā§ | -ā§¨ā§¯ā§Ģ.ā§¨ā§Ē% |
āĻ
āĻĒāĻžāĻ°ā§āĻļāĻ¨ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āĻ¯āĻžāĻļ | -ā§.ā§§ā§ŽÂ āĻā§ | ā§Šā§¯.ā§Ģā§Ž% |
āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | ā§Ģ.ā§Ŧā§Ŧ āĻā§ | -ā§Ŧā§¯.ā§Ļā§¨% |
āĻĢāĻžāĻāĻ¨ā§āĻ¯āĻžāĻ¨ā§āĻ¸āĻŋāĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | -ā§§ā§Ļ.ā§Žā§ŽÂ āĻ˛āĻž | ā§Ēā§.ā§Ēā§§% |
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ | -ā§§.ā§Ŧā§ŽÂ āĻā§ | -ā§§ā§¨ā§.ā§Šā§¯% |
āĻĢā§āĻ°āĻŋ āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§ | -ā§Ŧ.ā§Ŧā§Ŧ āĻā§ | ā§¨ā§Ē.ā§ā§Ž% |
āĻ¸āĻŽā§āĻĒāĻ°ā§āĻā§
Galapagos NV is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
āĻ¸ā§āĻĨāĻžāĻĒāĻŋāĻ¤ āĻšā§ā§āĻā§
ā§§ā§¯ā§¯ā§¯
āĻā§ā§āĻŦāĻ¸āĻžāĻāĻ
āĻāĻ°ā§āĻŽāĻāĻžāĻ°ā§
ā§Ŧā§Žā§Š